EBViously

EBViously

Pre-clinical
Munich, GermanyFounded 2020ebviously.com

IM is an underestimated acute disease characterized by fever, pharyngitis, lymphadenopathy, fatigue and lymphocytosis. It spontaneously resolves in the majority of patients, but severe complications occur such as airway obstruction, splenic rupture, hepatitis, encephalitis, hemophagocytic lymphohistiocytosis or other serious hematological disorders.

Founded
2020
Focus
Drug Delivery

About

IM is an underestimated acute disease characterized by fever, pharyngitis, lymphadenopathy, fatigue and lymphocytosis. It spontaneously resolves in the majority of patients, but severe complications occur such as airway obstruction, splenic rupture, hepatitis, encephalitis, hemophagocytic lymphohistiocytosis or other serious hematological disorders.

Company Info

TypePrivate
Founded2020
LocationMunich, Germany
StagePre-clinical
SIMILAR COMPANIES
300Microns
300Microns
Pre-clinical · Munich
BetaSense
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Mireca Medicines
Pre-clinical · Munich
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile